Latest news
University of Cincinnati trial aims to ease painful side effects in head and neck cancer - WKRCWKRC · Fri, 07 Aug 2026 20:20:08 GMTDostarlimab Monotherapy Elicits Responses in First-Line PD-L1-Positive HNSCC - OncLiveOncLive · Fri, 07 Aug 2026 15:25:50 GMTStudy identifies care steps that start head and neck cancer patients on lifesaving treatment sooner - Medical XpressMedical Xpress · Fri, 07 Aug 2026 13:00:03 GMTUnpacking Subgroup Data With First-Line Ipatasertib Plus Pembrolizumab in HNSCC - OncLiveOncLive · Thu, 06 Aug 2026 22:53:51 GMTDr Thomas on the Safety Profile of Frontline Ipatasertib Plus Pembrolizumab in HNSCC - OncLiveOncLive · Thu, 06 Aug 2026 21:37:16 GMTTelephone and 'Straight-to-Test' Model in Triaging Urgent Suspected Cancer Referrals in a Head and Neck Clinic - CureusCureus · Thu, 06 Aug 2026 21:36:24 GMTStudy identifies a novel direct drug target for head and neck squamous cell carcinoma - News-MedicalNews-Medical · Thu, 06 Aug 2026 12:27:00 GMTTargeting the roots of head and neck cancer: Why MDA-9 matters - Drug Target ReviewDrug Target Review · Thu, 06 Aug 2026 11:36:51 GMT